Supported by
Meliora Online is proudly supported by Team400, an Australian AI consultancy helping enterprises navigate practical AI implementation.
Enterprise transformation insights
Digital strategy and AI adoption for Australian enterprises.
Clear, practical analysis for leaders who need business cases, not hype. We focus on the steps that move budgets, teams, and outcomes.
What we cover
- AI strategy and operating models
- Process redesign and ROI tracking
- Vendor selection and governance
- Enterprise change management
What you can expect
- Frameworks you can take to the board
- Case notes from real projects
- Clear assumptions and tradeoffs
- Templates you can adapt fast
Latest posts
View all-
Narcolepsy Diagnostic Delay in Australia: The Numbers Are Still Bad
Average time from symptom onset to narcolepsy diagnosis in Australia has barely improved in a decade. The bottlenecks are clinically diagnosable.
-
When Wearable Sleep Data Helps the Clinical Conversation, and When It Does Not
Consumer wearable sleep data shows up in clinics every day now. Sometimes it adds signal. Often it adds noise. Here is where the line sits.
-
Home Sleep Test Accuracy in 2026: What the Latest Devices Actually Deliver
Type III and Type IV home sleep apnea tests have improved markedly. Where they're now clinically reliable, where they still miss, and what to order when.
-
Restless Legs Syndrome Management: What's Changed in 2026
Iron repletion protocols, alpha-2-delta ligands, and the long-overdue retreat from dopamine agonists. A practical RLS update for 2026 clinical practice.
-
Pediatric OSA Evaluation in May 2026: Where the Pathway Sits
Pediatric obstructive sleep apnoea evaluation has continued to evolve. Here's where the diagnostic pathway sits and where the practice variation is widest.
-
CPAP Mask Leak Management in May 2026: Where Practice Has Settled
Mask leak remains the dominant cause of CPAP non-adherence. Here's where the technology and clinical practice have actually moved in 2026.
-
CPAP Adherence in 2026: What the Latest Clinical Data Tells Us
Adherence remains the central challenge in OSA management. Recent data on patient interfaces, telemonitoring, and behavioural support shows what's actually moving the needle.
-
Narcolepsy Treatment Landscape in 2026: Where the Field Stands
The narcolepsy treatment options have expanded significantly. We look at the current pharmacological landscape and what the orexin agonist pipeline means for clinical practice.
-
Home Sleep Tests in 2026: Quality Has Improved, Limits Remain
Home sleep testing has continued to mature in 2026. Where it's now reliable enough for routine clinical use and where lab studies still matter.
-
Shift Work Sleep Disorder in 2026: Evidence-Based Management
What current evidence supports for managing shift work sleep disorder, and what the workplace conversation should look like.
-
Delayed Sleep Phase Disorder in Teenagers: Not Just Laziness
Teenagers who can't fall asleep until 2 AM and struggle to wake for school are often dismissed as lazy. For some, it's a genuine circadian rhythm disorder that needs treatment.
-
Sleep Divorce: When Separate Beds Improve Both Sleep and Relationships
Sleeping apart remains socially stigmatized, but research shows it can improve sleep quality and relationship satisfaction for many couples. Here's what the science says.
-
CPAP Compliance Tracking: How Much Data Is Your Machine Sending?
Modern CPAP machines track detailed usage data and send it to manufacturers and insurers. Here's what's being collected and who sees it.
-
Why Sleep Studies Cost So Much (And Why Alternatives Still Aren't Great)
A diagnostic sleep study in Australia costs $1,500-3,000 if you're paying privately. Here's what drives the cost and whether home sleep tests are worth it.
-
How Alcohol Actually Affects Your Sleep: Beyond the 'Nightcap' Myth
Alcohol helps you fall asleep faster but destroys sleep architecture in the second half of the night. The full picture is more complicated than most people realise.